Showing 9702 companies
Company Headquarters: Kuopio, Finland Founded: 1997 Workforce: 100+ Company Working: FinVector Vision Therapies was previously known as Ark Therapeutics Limited and it is a major player in the market which is involved in research and development of viral-based gene therapy products. The company develops and manufactures products used for gene therapy through its manufacturing facility which is approved by European Medicines Agency(EMA). It offers services and viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. The company operates in business segments namely, cell banking and viral seed stocks, R&D cell/gene therapy unit, platform process development / scale up, assay development and analytical testing, cGMP Manufacturing capabilities, FinVector aseptic filling capability, stability studies, Viral Vectors (including Adeno, AAV, Lenti), and Others.
Company Headquarters: Oxford, Oxfordshire, UK Founded: 1995 Workforce: 330+ Company Working: Oxford BioMedica is the first company to treat humans with the help of lentivirus and it is a leading player in the global cell and gene therapy market. The company develops and markets LentiVector technology which is widely used by physicians as a part of cell and gene therapy. The company operates in major markets in developed countries such as Americas and Europe. It has 20+ years’ experience in gene therapy segment and the company has conducted trials in more than 140 countries. The company has long term product related partnerships with major pharmaceutical players such as Novartis, orchard therapeutics, Sanofi, GlaxoSmithKline and has research and devleopmnet collaboration with Green Cross Labcell.
Company Headquarters: Keele, Northern Staffordshire, England Founded: 1992 Workforce: 201-500+ Company Working: Cobra Biologics was formerly known as RecipharmCobra Biologics Limited and operates as a subsidiary of Recip AB. it is a major player in the contract development and manufacturing (CDMO) segment which provides services such as pre-clinical, clinical, and commercial supply. The company operates in more than 18 counties and has manufacturing unit in Södertälje, Sweden. The company offers API services in pre-filled syringes, freeze drying/lyophilization, and injectable vial fill finish. It operates through DNA, viral vectors, technical proteins, microbiota, fill finish and other segments. The company has a strong research and development with more than 320 products in pipeline.
Unlock Verified Contacts
Access verified employee contacts
Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence